MADRIGAL PHARMACEUTICALS INC (MDGL)
US5588681057 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 3.09M | 2.73M | N/A | N/A | N/A | |||
| Cash Equivalents | 619.42M | 97.19M | 331.50M | 36.30M | 54.00M | |||
| Marketable Securities | 436.55M | 534.22M | 27.20M | 234.10M | 230.10M | |||
| Receivables | N/A | N/A | N/A | N/A | N/A | |||
| Inventories | 854.00K | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 14.04M | 3.15M | 2.60M | 1.30M | 1.00M | |||
| Total Current Assets | 1.07B | 637.28M | 361.40M | 271.70M | 285.20M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.33M | 3.27M | 1.20M | 1.60M | 1.80M | |||
| Intangibles | 5.00M | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | N/A | N/A | N/A | 1.65M | N/A | |||
| Total Non-Current Assets | 8.33M | 3.27M | 1.20M | 1.60M | 1.80M | |||
| TOTAL ASSETS | 1.08B | 640.55M | 362.60M | 273.30M | 287.00M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 92.81M | 90.51M | 92.10M | 55.50M | 45.50M | |||
| Accounts Payable | 21.53M | 28.04M | 23.80M | 21.40M | 1.00M | |||
| Other Current Liabilities | N/A | N/A | N/A | 76.84M | N/A | |||
| Total Current Liabilities | 114.34M | 118.55M | 115.90M | 76.80M | 46.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 116.14M | 115.48M | 49.30M | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 1.04M | 1.19M | 0.00 | 400.00K | 500.00K | |||
| Total Non-Current Liabilities | 117.18M | 116.67M | 49.30M | 400.00K | 400.00K | |||
| TOTAL LIABILITIES | 231.52M | 235.21M | 165.20M | 77.20M | 47.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.48B | -1.34B | -962.70M | -667.30M | -425.50M | |||
| Additional Paid In Capital | 2.33B | 1.74B | 1.16B | 863.50M | 665.40M | |||
| Common Shares | 2.00K | 2.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -172.00K | 468.00K | 0.00 | -100.00K | 0.00 | |||
| Shares Outstanding | 20.68M | 19.88M | 18.10M | 17.10M | 15.50M | |||
| Tangible Book Value per Share | 40.89 | 20.39 | 10.91 | 11.47 | 15.48 | |||
| Total Shareholders' Equity | 850.76M | 405.33M | 197.40M | 196.10M | 240.00M | |||
| TOTAL LIABILITIES AND EQUITY | 1.08B | 640.55M | 362.60M | 273.30M | 287.00M | |||
| Statistics | ||||||||
| Debt/Equity | 0.14 | 0.28 | 0.25 | N/A | N/A | |||
| Current Ratio | 9.39 | 5.38 | 3.12 | 3.54 | 6.12 | |||
| Return On Assets (ROA) | -41.05% | -58.33% | -81.47% | -88.47% | -70.45% | |||
| Return On Equity (ROE) | -52.22% | -92.18% | -149.65% | -123.30% | -84.25% | |||
All data in USD